Pressure, Comfort and Subjective Evaluation of FitFlop Products
Summary
This study aims to compare two different sole technologies in FitFlop shoes to see how they affect foot pressure, comfort, and tiredness during walking. FitFlop has a technology called Microwobbleboard, which uses three different densities in the sole to make shoes comfortable. They also developed a newer technology called Microbubbleboard, which uses a specially designed foam to achieve a similar comfortable feeling while using only one type of foam.
The goal of this research is to test these two shoes against each other to see which one performs better in terms of comfort, how pressure is spread across the foot, and how tired participants feel after walking. The study involves female participants walking on a treadmill while wearing shoes with either the Microwobbleboard or Microbubbleboard soles. Researchers will measure foot pressure and ask participants about their comfort and fatigue levels. The results will help FitFlop understand how well their new Microbubbleboard technology works compared to their traditional Microwobbleboard.
Eligibility
Eligible ages: 18 to 60
Accepts healthy participants: Yes
Inclusion criteria:
To participate in this research:
You must be female.
You need to be between 18 and 60 years old.
You should have been free from injuries for the past 6 months.
You need to be physically active and walk regularly
Your shoe size must be either US women's 6 or 7.5.
You will need to complete a basic physical activity readiness questionnaire (called a PAR-Q) to make sure you are healthy and okay to participate.
Exclusion criteria:
You are not eligible to participate in this research if:
You are male.
You are younger than 18 or older than 60.
You have had an injury in the last 6 months.
You have certain health conditions that could make walking difficult or unsafe (like heart problems, breathing issues, or muscle/bone injuries).
Your shoe size is not US women's 6 or 7.5.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Patrick Milner phone: 866-577-1989 patrick.milner@ucalgary.ca
Principal investigator:
Benno Maurus Nigg
Clinical trial:
No
REB-ID:
REB25-0627